期刊
JOURNAL OF BIOPHOTONICS
卷 12, 期 4, 页码 -出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/jbio.201800327
关键词
affinity chromatography; cancer screening; modified nucleoside; surface-enhanced Raman spectroscopy
资金
- distinguished young researcher of the universities of Fujian province [2017J01499]
- National Natural Science Foundation of Fujian, China [2017J01499]
- Innovation Team Development Plan by the Ministry of Education of China [IRT15R10]
- National Natural Science Foundation of China [61575043, U1605253, 81741008]
- Special Funds of the Central Government Guiding Local Science and Technology Development [17L3009]
- Startup Fund for scientific research, Fujian Medical University [2017XQ1209]
Modified nucleoside in urine samples is one of the most common biomarkers for cancer screening. Therefore, we developed a novel detection method for modified nucleoside detection in human urine. In this work, the modified nucleoside from real cancer patient's urine samples was first separated and purified using the affinity chromatography (AC) technology relying on its specific adsorption capacity. Then, surface-enhanced Raman spectroscopy (SERS) technology with the capability of single molecular detection was used to sensitively characterize the biomolecular features of modified nucleoside. A total of 141 high-quality SERS spectra of urinary modified nucleoside can be obtained from 50 gastric cancer patients and 43 breast cancer patients, as well as 48 healthy volunteers. Using principal component analysis combined with linear discriminant analysis (PCA-LDA), the diagnostic sensitivities for identifying gastric cancer vs normal, breast cancer vs normal, gastric cancer vs breast cancer were 84.0%, 76.7% and 82.0%, respectively, and the corresponding diagnostic specificities for each combination were 95.8%, 87.5% and 90.7%, respectively. These results show that this novel method based on urinary modified nucleoside detection combining AC and SERS technologies holds promising potential for developing a specific, non-invasive and label-free tool for cancer screening.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据